Data |
Ora |
Fonte |
Titolo |
12/11/2024 | 23:05 | PRNUS | Azitra, Inc. Announces Q3 2024 Financial Results and.. |
12/11/2024 | 23:01 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
29/10/2024 | 14:00 | BW | Azitra to Present at BIO-Europe 2024 |
11/10/2024 | 15:00 | BW | Azitra to Participate in the 2024 Maxim Healthcare Virtual.. |
09/10/2024 | 23:01 | EDGAR2 | Form ARS - Annual Report to Security Holders |
09/10/2024 | 22:55 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
24/9/2024 | 14:00 | BW | Azitra, Inc. Announces Late-Breaking Presentation at the.. |
18/9/2024 | 15:00 | BW | Azitra Receives Fast Track Designation for ATR-04 for Skin.. |
16/9/2024 | 23:47 | EDGAR2 | Form 144 - Report of proposed sale of securities |
06/9/2024 | 22:30 | BW | Azitra to Present at the H.C. Wainwright 26th Annual Global.. |
28/8/2024 | 14:30 | BW | Azitra Announces First Patient Dosed in Phase 1b Trial of.. |
22/8/2024 | 15:00 | BW | Azitra Receives Study May Proceed letter from the FDA for.. |
20/8/2024 | 22:15 | BW | Azitra Announces First Patient Screened and Scheduled to.. |
13/8/2024 | 00:23 | BW | Azitra, Inc. Announces Q2 2024 Financial Results and.. |
12/8/2024 | 23:15 | EDGAR2 | Form 8-K - Current report |
12/8/2024 | 23:02 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
02/8/2024 | 22:05 | EDGAR2 | Form SC 13D/A - General Statement of Acquisition of.. |
29/7/2024 | 22:01 | EDGAR2 | Form SC 13G - Statement of Beneficial Ownership by Certain.. |
26/7/2024 | 22:05 | EDGAR2 | Form 8-K - Current report |
25/7/2024 | 23:57 | BW | CORRECTING and REPLACING Azitra, Inc. Announces Closing of.. |
25/7/2024 | 20:15 | BW | Azitra, Inc. Announces Closing of Public Offering |
25/7/2024 | 12:03 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
24/7/2024 | 03:20 | BW | Azitra, Inc. Announces Pricing of $10.0 Million Public.. |
23/7/2024 | 14:00 | BW | Azitra, Inc. Strengthens Global Intellectual Property.. |
19/7/2024 | 23:27 | EDGAR2 | Form S-1/A - General form for registration of securities.. |
15/7/2024 | 23:11 | EDGAR2 | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
15/7/2024 | 12:21 | EDGAR2 | Form S-1 - General form for registration of securities under.. |
27/6/2024 | 22:05 | BW | Azitra, Inc. Announces Reverse Stock Split |
03/6/2024 | 22:30 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
31/5/2024 | 14:00 | BW | Azitra, Inc. Announces Presentation at the 2024 BIO.. |
24/5/2024 | 22:55 | EDGAR2 | Form PRE 14A - Other preliminary proxy statements |
17/5/2024 | 14:00 | BW | Azitra, Inc. Announces Positive Preclinical Data from ATR-04.. |
10/5/2024 | 14:00 | BW | Azitra, Inc. Announces Positive Preclinical Data of ATR-12.. |
09/5/2024 | 23:05 | EDGAR2 | Form 8-K - Current report |
09/5/2024 | 23:03 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09/5/2024 | 23:00 | BW | Azitra, Inc. Announces Q1 2024 Financial Results and.. |
22/4/2024 | 22:30 | BW | Azitra, Inc. Announces New Preclinical Data to be Presented.. |
18/4/2024 | 22:15 | BW | Azitra, Inc. to Present New Data at Three Upcoming.. |
15/3/2024 | 21:15 | BW | Azitra, Inc. Announces Full Year 2023 Financial Results and.. |
26/2/2024 | 22:10 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
26/2/2024 | 22:05 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
16/2/2024 | 22:05 | BW | Azitra, Inc. Announces Closing of Public Offering |
16/2/2024 | 02:42 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
16/2/2024 | 02:39 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
16/2/2024 | 02:38 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
15/2/2024 | 22:44 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
14/2/2024 | 15:15 | EDGAR2 | Form 8-K - Current report |
14/2/2024 | 04:09 | BW | Azitra, Inc. Announces Pricing of Public Offering |
19/1/2024 | 17:08 | EDGAR2 | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
19/1/2024 | 15:19 | EDGAR2 | Form S-1 - General form for registration of securities under.. |